Its licence doesn't allow us to show a copy here.
We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The adjusted odds ratio of 0.54 vs. STEMI is not reassuring. These patients had far more events than those with NSTEMI-no-ACO, and this invites comment on some biases.”
No takes yet. Share an insight, caveat, or question.
Smith et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: